We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current HBIO market cap is 58.45M. The company's latest EPS is USD -0.0783 and P/E is -17.11.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 25.36M | 28.15M | 24.51M | 23.1M | 21.97M |
| Operating Income | -933k | 282k | -2.28M | -2.07M | -3.47M |
| Net Income | -1.24M | -1.82M | -4.69M | -2.93M | -4.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 116.18M | 102.1M | 118.9M | 113.57M | 112.25M |
| Operating Income | 1.84M | 221k | 2.07M | -6.93M | 1.89M |
| Net Income | -4.69M | -7.81M | -288k | -9.52M | -3.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 139.74M | 137.37M | 133.16M | 128.91M | 131.24M |
| Total Liabilities | 65.45M | 64.29M | 64.35M | 61.67M | 65.92M |
| Total Equity | 74.29M | 73.07M | 68.81M | 67.25M | 65.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 164.87M | 156.25M | 162.34M | 145.36M | 137.37M |
| Total Liabilities | 83.18M | 79.57M | 78.94M | 73.14M | 64.29M |
| Total Equity | 81.69M | 76.68M | 83.4M | 72.22M | 73.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.73M | 14.03M | 1.4M | 557k | -285k |
| Investing | -738k | -1.8M | -225k | 233k | -878k |
| Financing | -8.02M | -12.13M | -1.06M | -878k | 1.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.05M | 9.33M | 1.26M | 1.15M | 14.03M |
| Investing | -229k | -1.4M | -1.35M | -1.59M | -1.8M |
| Financing | -7.62M | -7.97M | -252k | -2.84M | -12.13M |
| Market Cap | 58.45M |
| Price to Earnings Ratio | -17.11 |
| Price to Sales Ratio | 0.52 |
| Price to Cash Ratio | 13.65 |
| Price to Book Ratio | 0.8 |
| Dividend Yield | - |
| Shares Outstanding | 43.62M |
| Average Volume (1 week) | 241.27k |
| Average Volume (1 Month) | 208.39k |
| 52 Week Change | -71.85% |
| 52 Week High | 4.93 |
| 52 Week Low | 1.34 |
| Spread (Intraday) | 0.77 (36.49%) |
| Company Name | Harvard Bioscience Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.harvardbioscience.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
